State of New Jersey Common Pension Fund D’s Esperion Therapeutics ESPR Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-36,875	Closed	-$1.72M	–	1612
2019 Q2	$1.72M	Hold	36,875	–	–	0.01%	764
2019 Q1	$1.48M	Hold	36,875	–	–	0.01%	780
2018 Q4	$1.7M	Hold	36,875	–	–	0.01%	735
2018 Q3	$1.64M	Hold	36,875	–	–	0.01%	782
2018 Q2	$1.45M	Hold	36,875	–	–	0.01%	828
2018 Q1	$2.67M	Hold	36,875	–	–	0.01%	719
2017 Q4	$2.43M	Hold	36,875	–	–	0.01%	716
2017 Q3	$1.85M	Buy	+36,875	New	+$1.78M	0.01%	756

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State of New Jersey Common Pension Fund D's ESPR Position: Q3 2019 in Review

State of New Jersey Common Pension Fund D sold out of Esperion Therapeutics (ESPR) in Q3 2019, closing a stake of 36,875 shares — an estimated $1.72M sold.

State of New Jersey Common Pension Fund D first reported a position in ESPR in Q3 2017 and held it in 8 quarters. The position peaked at $2.67M in Q1 2018. 152 funds tracked by Wall St. Rank hold ESPR as of Q3 2019.

State of New Jersey Common Pension Fund D reported no remaining Esperion Therapeutics position as of Q3 2019 after selling out during the quarter.
State of New Jersey Common Pension Fund D sold 36,875 Esperion Therapeutics shares in Q3 2019, an estimated $1.72M.
State of New Jersey Common Pension Fund D first reported a position in Esperion Therapeutics in Q3 2017 and held it in 8 quarters.
State of New Jersey Common Pension Fund D's Esperion Therapeutics position peaked at $2.67M in Q1 2018.
152 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2019.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2019, filed 23 Oct 2019.